Home Cart Sign in  
Chemical Structure| 2096992-20-8 Chemical Structure| 2096992-20-8

Structure of MELK-8a HCl
CAS No.: 2096992-20-8

Chemical Structure| 2096992-20-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MELK-8a is a maternal embryonic leucine zipper kinase (MELK) inhibitor.

Synonyms: NVS-MELK8a hydrochloride; MELK-8a (hydrochloride); NVS-MELK8a

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MELK-8a HCl

CAS No. :2096992-20-8
Formula : C25H33ClN6O
M.W : 469.02
SMILES Code : CN(CC1)CCN1C2=CC=C(C=C2)N3N=CC(C4=CC=NC=C4OCC5CCNCC5)=C3.Cl
Synonyms :
NVS-MELK8a hydrochloride; MELK-8a (hydrochloride); NVS-MELK8a
MDL No. :N/A

Safety of MELK-8a HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of MELK-8a HCl

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLaS3 cells 3 µM 12 hours To evaluate the effect of NVS-MELK8a on the cell cycle, results showed that NVS-MELK8a delays mitotic entry PMC7039562
MDA-MB-468 cells 1 µM 30 minutes To evaluate the selectivity of NVS-MELK8a, results showed that NVS-MELK8a is highly selective for MELK PMC7039562
MDA-MB-231 cells 1.7 µM 72 hours To evaluate the effect of NVS-MELK8a on cell viability, results showed that NVS-MELK8a decreases triple-negative breast cancer cell viability PMC7039562

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.66mL

2.13mL

1.07mL

21.32mL

4.26mL

2.13mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories